Skip to content

13F-HR filed by Aquilo Capital Management, LLC

Aquilo Capital Management, LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 13 holding rows worth $55,776,888.

Accession
0001591986-25-000004
Filed
2025-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 13 entries on the cover page, a total value of $55,776,888 stated on the cover page (in dollars after the unit check, H1), rows summing to $55,776,888 with VALUE read as dollars as filed, 13F file number 028-18892. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Amgen Inc.031162100COM60,000$18,693,000dollars as filedcall
BLUEPRINT MEDICINES CORP09627Y109COM83,926$7,428,290dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM550,130$7,008,656dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM81,692$3,950,625dollars as filed
KYMERA THERAPEUTICS INC501575104COM138,521$3,791,320dollars as filed
PRECISION BIOSCIENCES INC74019P207COM NEW726,149$3,463,731dollars as filed
ARVINAS INC04335A105COM360,766$2,532,577dollars as filed
REGENXBIO INC75901B107COM271,302$1,939,809dollars as filed
ADICET BIO INC007002108COM2,456,194$1,854,426dollars as filed
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS171,695$1,457,691dollars as filed
IMMATICS N.VN44445109SHS304,902$1,375,108dollars as filed
REPARE THERAPEUTICS INC760273102COM1,293,715$1,275,474dollars as filed
ZYMEWORKS INC98985Y108COM84,482$1,006,181dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001591986-25-000004this filing2025-05-15acceptance time not in the bulk data set